HealthCor Management as of March 31, 2022
Portfolio Holdings for HealthCor Management
HealthCor Management holds 64 positions in its portfolio as reported in the March 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Biogen Idec (BIIB) | 5.6 | $85M | 402k | 210.60 | |
Boston Scientific Corporation (BSX) | 5.5 | $82M | 1.9M | 44.29 | |
Horizon Therapeutics Pub L SHS | 5.0 | $75M | 710k | 105.21 | |
BioMarin Pharmaceutical (BMRN) | 4.0 | $59M | 769k | 77.10 | |
Natera (NTRA) | 3.9 | $59M | 1.4M | 40.68 | |
Abbott Laboratories (ABT) | 3.8 | $57M | 485k | 118.36 | |
Spdr Ser Tr S&p Biotech Call Option (XBI) | 3.6 | $54M | 600k | 89.88 | |
Centene Corporation (CNC) | 3.6 | $53M | 635k | 84.19 | |
AmerisourceBergen (COR) | 3.4 | $51M | 331k | 154.71 | |
Humana (HUM) | 3.2 | $48M | 109k | 435.17 | |
Cooper Cos Com New | 3.0 | $45M | 109k | 417.59 | |
Envista Hldgs Corp (NVST) | 3.0 | $45M | 915k | 48.71 | |
Cytokinetics Com New (CYTK) | 2.8 | $42M | 1.1M | 36.81 | |
Abbvie (ABBV) | 2.7 | $41M | 254k | 162.11 | |
Livanova SHS (LIVN) | 2.7 | $41M | 502k | 81.83 | |
Incyte Corporation (INCY) | 2.7 | $40M | 500k | 79.42 | |
Bristol Myers Squibb (BMY) | 2.6 | $39M | 530k | 73.03 | |
Becton, Dickinson and (BDX) | 2.5 | $38M | 142k | 266.00 | |
UnitedHealth (UNH) | 2.5 | $37M | 73k | 509.98 | |
Anthem (ELV) | 2.4 | $36M | 73k | 491.22 | |
Teleflex Incorporated (TFX) | 2.3 | $35M | 99k | 354.83 | |
Universal Hlth Svcs CL B (UHS) | 2.2 | $33M | 228k | 144.95 | |
McKesson Corporation (MCK) | 2.0 | $29M | 96k | 306.13 | |
CVS Caremark Corporation (CVS) | 1.9 | $29M | 287k | 101.21 | |
Danaher Corporation (DHR) | 1.9 | $29M | 98k | 293.33 | |
Revance Therapeutics (RVNC) | 1.9 | $28M | 1.4M | 19.50 | |
Amgen (AMGN) | 1.8 | $26M | 109k | 241.82 | |
Tenet Healthcare Corp Com New (THC) | 1.6 | $24M | 284k | 85.96 | |
Chemocentryx | 1.6 | $24M | 957k | 25.07 | |
Pet Acquisition LLC -Class A (WOOF) | 1.6 | $24M | 1.2M | 19.57 | |
Henry Schein (HSIC) | 1.5 | $22M | 255k | 87.19 | |
Syndax Pharmaceuticals (SNDX) | 1.4 | $21M | 1.2M | 17.38 | |
Cardinal Health (CAH) | 1.2 | $18M | 317k | 56.70 | |
Research Alliance Corp Ii Com Cl A | 0.9 | $13M | 1.3M | 9.76 | |
Pfizer (PFE) | 0.8 | $13M | 243k | 51.77 | |
Hca Holdings (HCA) | 0.8 | $12M | 49k | 250.62 | |
Stryker Corporation (SYK) | 0.8 | $12M | 44k | 267.34 | |
Affimed Therapeutics B V | 0.5 | $7.5M | 1.7M | 4.37 | |
Quanterix Ord (QTRX) | 0.5 | $7.2M | 247k | 29.19 | |
Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.5 | $7.1M | 200k | 35.27 | |
Regeneron Pharmaceuticals (REGN) | 0.4 | $6.7M | 9.6k | 698.43 | |
ImmunoGen | 0.4 | $6.2M | 1.3M | 4.76 | |
Hyperfine Com Cl A (HYPR) | 0.4 | $6.2M | 1.8M | 3.54 | |
Rapt Therapeutics (RAPT) | 0.4 | $5.8M | 264k | 21.99 | |
Cano Health Com Cl A | 0.3 | $4.5M | 712k | 6.35 | |
BioCryst Pharmaceuticals (BCRX) | 0.2 | $3.7M | 229k | 16.26 | |
Alkermes SHS (ALKS) | 0.2 | $3.7M | 141k | 26.31 | |
Ishares Tr Ishares Biotech (IBB) | 0.2 | $3.7M | 28k | 130.30 | |
Stereotaxis Com New (STXS) | 0.2 | $3.1M | 822k | 3.73 | |
Merus N V (MRUS) | 0.2 | $3.0M | 112k | 26.44 | |
Neurocrine Biosciences (NBIX) | 0.1 | $2.2M | 24k | 93.74 | |
Leap Therapeutics | 0.1 | $1.9M | 1.1M | 1.75 | |
Ikena Oncology (IKNA) | 0.1 | $1.8M | 288k | 6.10 | |
Galapagos Nv Spon Adr (GLPG) | 0.1 | $1.5M | 24k | 62.01 | |
Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.1 | $1.4M | 9.2k | 155.62 | |
Geron Corporation (GERN) | 0.1 | $1.2M | 900k | 1.36 | |
Pacira Pharmaceuticals (PCRX) | 0.1 | $1.1M | 14k | 76.31 | |
Pyxis Oncology Common Stock (PYXS) | 0.1 | $879k | 218k | 4.04 | |
Intra Cellular Therapies (ITCI) | 0.1 | $830k | 14k | 61.16 | |
Longview Acquisition Corp Ii *w Exp 99/99/999 | 0.0 | $179k | 427k | 0.42 | |
Eqrx *w Exp 12/17/202 | 0.0 | $81k | 100k | 0.81 | |
Orion Acquisition Corp *w Exp 02/19/202 | 0.0 | $43k | 137k | 0.31 | |
Medicus Sciences Acquisition *w Exp 02/12/202 | 0.0 | $35k | 83k | 0.42 | |
Eucrates Biomedical Acqu Cor *w Exp 10/23/202 | 0.0 | $15k | 78k | 0.19 |